TBVI provides technical support for product and clinical development to its partners through its Product Advancement eXperts (PAX). The PAX advises and guides vaccine researchers and developers in TBVI’s R&D network while they move their candidates from concept to clinical development. The PAX supports the definition of a final target product profile (TPP) and the development of subsequent plans for product development, characterization and clinical testing. In addition, the PAX provides technical advice to relevant stakeholders.
Get in touch at tbvi@info.eu
info@tbvi.eu
+31 (0) 6 1099 5196
Runderweg 6
8219 PK Lelystad